BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2026.
World J Cardiol. Feb 26, 2026; 18(2): 114960
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114960
Figure 2
Figure 2 Mechanistic overview of residual cardiovascular risk (low-density lipoprotein-independent lipid and inflammatory pathways). TRLs: Triglyceride-rich lipoproteins; LPL: Lipoprotein lipase; eNOS: Endothelial nitric oxide synthase; LDL: Low-density lipoprotein; Lp(a): Lipoprotein(a); HDLC: High-density lipoprotein cholesterol; Apo B: Apolipoprotein B; IL: Interleukin; TNF: Tumor necrosis factor; hsCRP: High-sensitivity C-reactive protein; LDL-C: Low-density lipoprotein-cholesterol.


Write to the Help Desk